Acompanhe as Notícias da Recifes

Telehealth-supported home-based exercise (HBE) achieves comparable short-term improvements to supervised exercise among lymphoma survivors entering cardio-oncology rehabilitation (CORE), according to a study published in Cancer Control.

More than 50 million Americans live in counties without a radiation oncology practice site, and millions more are at risk, according to a new study published today in the International Journal of Radiation Oncology*Biology*Physics (Red Journal), the flagship journal of the Americ

A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet Research. Authored by JMIR Correspondent Benedette Cuffari, "AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy" rep

A new study from University Hospitals Connor Whole Health reports that an insurance-supported integrative oncology program resulted in clinically meaningful improvements in cancer-related symptoms like pain, stress, anxiety, depression, nausea and fatigue. The findings highlight

Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.

A new study shows that a smoking cessation treatment program delivered in community oncology care settings can nearly double quit rates for patients with cancer who currently smoke. Investigators from Mass General Brigham Cancer Institute and Memorial Sloan Kettering Cancer Cente

A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Finanças.

Os medicamentos GLP-1 estão no centro de um debate acalorado após estudos apresentados no maior congresso de oncologia do mundo. Entenda o que realmente sabemos — e o que ainda é especulação.

Um estudo sugere que a triiodotironina, ou T3, hormônio usado no tratamento do hipotireoidismo, pode reforçar a quimioterapia contra o meduloblastoma e reduzir o risco de o tumor voltar após o tratamento.